Synbiotics in Metabolic Disorders - Mishra, Neeraj; Ashique, Sumel; Farid, Arshad;(ed.) - Prospero Internet Bookshop
Basket (0)
Wishlist (0)
Your personal newsletter
__

Synbiotics in Metabolic Disorders: Mechanisms, Therapeutic Potential, and Future Perspectives
 
Product details:
ISBN13:9781032702414
ISBN10:1032702419
Binding:Hardback
No. of pages:274 pages
Size:280x210 mm
Weight:666 g
Language:English
Illustrations: 36 Illustrations, black & white; 36 Line drawings, color; 20 Tables, black & white
698
Category:

Synbiotics in Metabolic Disorders

Mechanisms, Therapeutic Potential, and Future Perspectives
 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:
Publisher's listprice:
GBP 130.00
Estimated price in HUF:
68 250 HUF (65 000 HUF + 5% VAT)
Why estimated?
 
Your price:
54 600 (52 000 HUF + 5% VAT )
discount is: 20% (approx 13 650 HUF off)
Discount is valid until: 31 December 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
Add to basket
  Piece(s)

 
Short description:

This book examines the potential of prebiotics, probiotics, and synbiotics in managing metabolic disorders and their therapeutic applications. It explores their impact on oxidative stress, inflammation, lipid metabolism, and blood pressure, offering valuable insights for researchers in biomaterials and pharmaceutical sciences.

Long description:

This book explores the potential role of prebiotics, probiotics, and synbiotics in managing various metabolic disorders, chronic diseases, and metabolic syndromes. The initial chapter provides an overview of metabolic disorders, including their classification, symptoms, and underlying causes. Additionally, the chapter discusses the intricate signaling pathways and mechanisms through which prebiotics, probiotics, and synbiotics interact with the human body in relation to type-2 diabetes, obesity, Phenylketonuria, and Hemochromatosis. Additionally, the book highlights the potential impact of probiotics and synbiotics on oxidative stress, inflammation, lipid metabolism, and blood pressure. Furthermore, this book focuses on the gut-brain axis and how synbiotics may influence neurotransmitter metabolism. With an emphasis on the gut-microbiota axis, this book presents a compelling narrative that explores the rationality behind synbiotic use and offers a glimpse into future perspectives for managing metabolic disorders effectively. This book is intended for researchers in the fields of nutraceuticals, nanomedicine, endocrinology, nutrition, gastroenterology, and metabolic medicine who are working in the field of probiotics, prebiotics, and symbiotics for the treatment of metabolic disorders.

Table of Contents:
Chapter 1. An introduction on metabolic disorders. Chapter 2. Targeting Signaling Pathway & Mechanism of Prebiotics, Probiotics and Synbiotics to Manage Metabolic Disorders. Chapter 3. Potential Role of Probiotics, Prebiotics and Synbiotics in Management of Metabolic Syndrome and Chronic Metabolic Disease. Chapter 4. Synbiotics & Gut Micro flora: Mechanisms and Therapeutic. Chapter 5. Exploring Gut Microbiota as Therapeutic Target to maintain Metabolic Health. Chapter 6. Role of Synbiotic Supplements in the Treatment and Prevention of Obesity. Chapter 7. Therapeutic Potential of Gut Microbiota in Metabolic Disorders. Chapter 8. The Impact of probiotic and synbiotic supplementation on oxidative stress and inflammation. Chapter 9. Correlation and Successive Role of Synbiotics to Manage Blood Pressure. Chapter 10. Synbiotics: A novel paradigm for Phenylketonuria management by targeting gut-microbiota and gut-brain axis. Chapter 11. Role of synbiotic intake in Hemochromatosis Management. Chapter 12. Correlation Between Synbiotic supplements and Lipid Metabolism: A Novel Strategy to Counterattack Metabolic Disorders. Chapter 13. Probiotics, Prebiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota. Chapter 14. Impact of Bacterial metabolites on gut environment to manage metabolic disorders. Chapter 15. The Potential Role of Prebiotics, Probiotics, and Synbiotics in Cancer Prevention and Therapy. Chapter 16. Key Regulatory Aspects of Prebiotics, Probiotics, and Synbiotics in management of metabolic disorders. Chapter 17. Synbiotics: Present Status and Future Perspectives to Control Metabolic Disorders. Chapter 18. Role of Synbiotics in Managing Metabolic Disorders: A Conclusion.